269 related articles for article (PubMed ID: 24625581)
1. High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma.
Chi PD; Liu W; Chen H; Zhang JP; Lin Y; Zheng X; Liu W; Dai S
PLoS One; 2014; 9(3):e91080. PubMed ID: 24625581
[TBL] [Abstract][Full Text] [Related]
2. Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib.
Tang M; Song C; Zhang Y; Xu X; Wang C; Zhang Z; Chen T
Lipids Health Dis; 2021 Nov; 20(1):165. PubMed ID: 34801029
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of a reduction in the level of high-density lipoprotein-cholesterol in patients with non-small-cell lung cancer undergoing radical resection and adjuvant chemotherapy: a retrospective observational study.
Luo F; Zeng KM; Cao JX; Zhou T; Lin SX; Ma WJ; Yang YP; Zhang ZH; Lu FT; Huang Y; Zhao HY; Zhang L
Lipids Health Dis; 2021 Sep; 20(1):109. PubMed ID: 34544437
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Serum Triglyceride to High-Density Lipoprotein Cholesterol Ratio Can Predict Prognosis in Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study.
Li J; Ma C; Yuan X; Wang X; Li N; Yu R; Liao H
Curr Oncol; 2022 Aug; 29(9):6125-6136. PubMed ID: 36135050
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
[TBL] [Abstract][Full Text] [Related]
6. [The prognostic value of detection of serum C-reactive protein in the patients with stage I lung cancer].
Xu Y; Li Z; Shen-Tu Y
Zhongguo Fei Ai Za Zhi; 2011 May; 14(5):400-3. PubMed ID: 21569644
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of C-reactive protein in patients with stage I non-small cell lung cancer].
Shen L; Li ZM; Lu S
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):442-6. PubMed ID: 21875485
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
9. High BMI and low HDL-C predict the chemotherapy-related hepatic dysfunction in Chinese advanced NSCLC patients.
Lv Y; Ding XS; Li Y; An X; Miao LY
Cancer Biomark; 2016; 16(1):89-97. PubMed ID: 26835709
[TBL] [Abstract][Full Text] [Related]
10. The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer.
Li X; Tang H; Wang J; Xie X; Liu P; Kong Y; Ye F; Shuang Z; Xie Z; Xie X
Breast; 2017 Apr; 32():1-6. PubMed ID: 27939967
[TBL] [Abstract][Full Text] [Related]
11. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
Jiang AG; Chen HL; Lu HY
BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of preoperative serum triglycerides and high-density lipoproteins cholesterol in patients with non-small cell lung cancer: a retrospective study.
Ma C; Wang X; Guo J; Liu P
Lipids Health Dis; 2021 Oct; 20(1):69. PubMed ID: 34598703
[TBL] [Abstract][Full Text] [Related]
13. Progression of non-small cell lung cancer: diagnostic and prognostic utility of matrix metalloproteinase-2, C-reactive protein and serum amyloid A.
Kanoh Y; Abe T; Masuda N; Akahoshi T
Oncol Rep; 2013 Feb; 29(2):469-73. PubMed ID: 23135313
[TBL] [Abstract][Full Text] [Related]
14. Decreased pretreatment serum cholesterol level is related with poor prognosis in resectable non-small cell lung cancer.
Li JR; Zhang Y; Zheng JL
Int J Clin Exp Pathol; 2015; 8(9):11877-83. PubMed ID: 26617943
[TBL] [Abstract][Full Text] [Related]
15. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers.
Akamine T; Takada K; Toyokawa G; Kinoshita F; Matsubara T; Kozuma Y; Haratake N; Takamori S; Hirai F; Tagawa T; Okamoto T; Yoneshima Y; Okamoto I; Shimokawa M; Oda Y; Nakanishi Y; Maehara Y
Surg Oncol; 2018 Mar; 27(1):88-94. PubMed ID: 29549910
[TBL] [Abstract][Full Text] [Related]
16. Decreased Serum Lipid Levels and Ratios Correlate with Low Prevalence of Coronary Heart Disease in Patients with Parkinson's Disease.
Bao M; Hu R; Chen Y; Wang N; Xue H; He J; Jin J; Kong W; Ke G; Xue Q
Clin Lab; 2018 Sep; 64(9):1413-1419. PubMed ID: 30274018
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum C-reactive protein level in non-small cell lung cancer.
Hara M; Matsuzaki Y; Shimuzu T; Tomita M; Ayabe T; Enomoto Y; Onitsuka T
Anticancer Res; 2007; 27(4C):3001-4. PubMed ID: 17695486
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of preoperative serum high density lipoprotein cholesterol levels in soft tissue sarcoma.
Que Y; Jiang F; Liu L; Li Y; Chen Y; Qiu H; Zhou Z; Zhang X
Medicine (Baltimore); 2015 May; 94(18):e844. PubMed ID: 25950696
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
